Literature DB >> 17704902

[A 65-year-old female patient with breast cancer accompanied by thrombocytopenia and hyperfibrinolysis].

C Aulmann1, P Seufert, M Sandherr, G Schlimok, R Schulze, D Oruzio.   

Abstract

Tumor diseases can be accompanied by paraneoplastic syndromes. Low platelet counts and hyperfibrinolysis led to the diagnosis of recurrent breast cancer in this case. A tumour disease with disturbed hemostasis caused by both plasmatic coagulation and thrombocytopenia has not yet been reported.

Entities:  

Mesh：

Year:  2007        PMID： 17704902     DOI： 10.1007/s00108-007-1920-z

Source DB:  PubMed          Journal:  Internist (Berl)        ISSN： 0020-9554            Impact factor:   0.743


  11 in total

1.  Thrombotic thrombocytopenic purpura in metastatic carcinoma of the breast.

Authors:  N von Bubnoff; M Sandherr; F Schneller; C Peschel
Journal:  Am J Clin Oncol       Date:  2000-02       Impact factor: 2.339

Review 2.  Chronic idiopathic thrombocytopenic purpura.

Authors:  J N George; M A el-Harake; G E Raskob
Journal:  N Engl J Med       Date:  1994-11-03       Impact factor: 91.245

Review 3.  Idiopathic thrombocytopenic purpura associated with breast cancer: a case report and review of the current literature.

Authors:  L F Porrata; S Alberts; C Hook; C A Hanson
Journal:  Am J Clin Oncol       Date:  1999-08       Impact factor: 2.339

4.  High preoperative plasma D-dimer level is associated with advanced tumor stage and short survival after curative resection in patients with colorectal cancer.

Authors:  M Oya; Y Akiyama; T Okuyama; H Ishikawa
Journal:  Jpn J Clin Oncol       Date:  2001-08       Impact factor: 3.019

5.  A prospective study on the prognostic significance of urokinase-type plasminogen activator levels in breast cancer tissue.

Authors:  E Shiba; S J Kim; T Taguchi; M Izukura; T Kobayashi; J Furukawa; E Yayoi; E Shin; Y Takatsuka; H Koyama; S Takai
Journal:  J Cancer Res Clin Oncol       Date:  1997       Impact factor: 4.553

6.  Disseminated intravascular coagulation in solid tumors: clinical and pathologic study.

Authors:  S Sallah; J Y Wan; N P Nguyen; L R Hanrahan; G Sigounas
Journal:  Thromb Haemost       Date:  2001-09       Impact factor: 5.249

Review 7.  The fibrinolytic system in neoplasia.

Authors:  W R Bell
Journal:  Semin Thromb Hemost       Date:  1996       Impact factor: 4.180

8.  Prognostic significance of hemostatic parameters in patients with lung cancer.

Authors:  Ebru Unsal; Figen Atalay; Sükran Atikcan; Aydin Yilmaz
Journal:  Respir Med       Date:  2004-02       Impact factor: 3.415

9.  Hemostatic abnormalities in malignancy, a prospective study of one hundred eight patients. Part I. Coagulation studies.

Authors:  N C Sun; W M McAfee; G J Hum; J M Weiner
Journal:  Am J Clin Pathol       Date:  1979-01       Impact factor: 2.493

Review 10.  Association of breast cancer and immune thrombocytopenic purpura.

Authors:  Celalettin Ustun; Paul Dainer; Linda Hendricks; Charles Todd Bruker; Russell Burgess
Journal:  South Med J       Date:  2002-11       Impact factor: 0.954
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.